References
- Barkema HW, Schukken YH, Zadoks RN. Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. Journal of Dairy Science 89, 1877–95, 2006 doi: 10.3168/jds.S0022-0302(06)72256-1
- Harmon RJ. Symposium – mastitis and genetic evaluation for somatic-cell count – physiology of mastitis and factors affecting somatic-cell counts. Journal of Dairy Science 77, 2103–12, 1994 doi: 10.3168/jds.S0022-0302(94)77153-8
- McDougall S. Efficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cows. New Zealand Veterinary Journal 46, 226–32, 1998 doi: 10.1080/00480169.1998.36094
- McDougall S. Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin. New Zealand Veterinary Journal 51, 111–6, 2003 doi: 10.1080/00480169.2003.36349
- McDougall S, Arthur D, Bryan M, Vermunt J, Weir A. Clinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antibiotics. New Zealand Veterinary Journal 55, 161–70, 2007 doi: 10.1080/00480169.2007.36762
- McDougall S, Bryan M, Tiddy R. Effect of treatment with the nonsteroidal antiinflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis. Journal of Dairy Science 92, 4421–31, 2009 doi: 10.3168/jds.2009-2284
- McDougall S, Hussein H, Petrovski KR. Antimicrobial resistance in Staphylococcus aureus, Streptococcus uberis and Streptococcus dysgalactiae from dairy cows with mastitis. New Zealand Veterinary Journal 62, 68–76, 2014 doi: 10.1080/00480169.2013.843135
- Moroni P, Pisoni G, Antonini M, Villa R, Boettcher P, Carli S. Antimicrobial drug susceptibility of Staphylococcus aureus from subclinical bovine mastitis in Italy. Journal of Dairy Science 89, 2973–6, 2006 doi: 10.3168/jds.S0022-0302(06)72569-3
- Petrovski KR, Laven RA, Lopez-Villalobos N. A descriptive analysis of the antimicrobial susceptibility of mastitis-causing bacteria isolated from samples submitted to commercial diagnostic laboratories in New Zealand (2003–2006). New Zealand Veterinary Journal 59, 59–66, 2011 doi: 10.1080/00480169.2011.552853
- *Plumb DC. Veterinary Drug Handbook. 4th Edtn. Blackwell Publishing Professional, Ames, IA, USA, 2002
- Sears PM, Smith BS, English PB, Herer PS, Gonzalez RN. Shedding pattern of Staphylococcus aureus from bovine intramammary infections. Journal of Dairy Science 73, 2785–9, 1990 doi: 10.3168/jds.S0022-0302(90)78964-3
- *Snyderman R, Gallin JI, Goldstein IM. Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York, USA, 1992
- Sol J, Sampimon OC, Barkema HW, Schukken YH. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. Journal of Dairy Science 83, 278–84, 2000 doi: 10.3168/jds.S0022-0302(00)74875-2
- Wraight MD. A comparative efficacy trial between cefuroxime and cloxacillin as intramammary treatments for clinical mastitis in lactating cows on commercial dairy farms. New Zealand Veterinary Journal 51, 26–32, 2003 doi: 10.1080/00480169.2003.36326